TY  - JOUR
AU  - López-Sánchez, C
AU  - Valcárcel, D
AU  - Gómez, V
AU  - López-Jiménez, J
AU  - Serrano, D
AU  - Rubio, V
AU  - Solano, C
AU  - Vázquez, L
AU  - Ruiz, I
AU  - Grupo Español de Trasplante Hematopoyético (GETH)
PY  - 2020
DO  - 10.37201/req/094.2019
UR  - http://hdl.handle.net/10668/15105
T2  - Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
AB  - The fungal infections remain an important problem in the allogeneic stem cell trasnsplantation (allo-SCT) setting and thus, anti-fungal prophylaxis is commonly used. The antifungal drug should offer activity, at least against Candida and Aspergillus...
LA  - en
KW  - Stem cell transplantation
KW  - micafungin
KW  - prophylaxis
KW  - Allografts
KW  - Antifungal Agents
KW  - Drug Interactions
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Invasive Fungal Infections
KW  - Male
KW  - Micafungin
KW  - Middle Aged
KW  - Mycoses
KW  - Retrospective Studies
KW  - Spain
TI  - Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).
TY  - research article
VL  - 33
ER  -